01 /What it is
Tirzepatide is a synthetic incretin analog that engages both the GIP and GLP-1 receptors. It is one of the most studied dual incretin agonists in current metabolic research and is a prescription medicine in regulated markets.
02 /How it works
In research models, Tirzepatide is investigated as a co agonist at GIP and GLP-1 receptors. Its mechanism is studied in incretin pathway research alongside selective GLP-1 agonists and selective GIP agonists.
03 /What researchers explore it for
Researchers have explored Tirzepatide in incretin pathway research, in body composition research, and in comparative research alongside selective GLP-1 agonists.
04 /Safety and interactions
Research interactions of note include overlapping pathway engagement with other incretin receptor agonists. Tirzepatide is also a prescription medicine in regulated markets. Tirzepatide is for laboratory research use only and is not for human consumption. Not medical advice. Not intended to diagnose, treat, cure, or prevent any disease.
05 /Research notes
Compound family: dual incretin (GIP plus GLP-1) receptor agonists. Frequently compared with Semaglutide, Liraglutide, and Retatrutide. The Apothify library lists Tirzepatide for encyclopedia coverage only.
Related peptides
Semaglutide · Liraglutide · Retatrutide